Clinical Trial Update: Effect of Fluvoxamine on Cognition, Behavior, Symptoms and mRNA and Protein Expression in Schizophrenia Patients [NA]

View source ↗

Summary

Clinical trial investigating the effects of fluvoxamine on cognition, behavior, symptoms, and mRNA/protein expression in patients with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Fluvoxamine (fluvoxamine)

Snippet

Sponsor: Sha'ar Menashe Mental Health Center | Conditions: SCHIZOPHRENIA 1 (Disorder) | NA | Status: UNKNOWN